Squarepoint
BSX icon

Squarepoint’s Boston Scientific BSX Stock Holding History

Squarepoint’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8M Buy
267,300
+194,200
+266% +$15.5M 0.02% 794
2025
Q4 		$6.97M Sell
73,100
-29,800
-29% -$2.92M 0.01% 1252
2025
Q3 		$10M Sell
102,900
-438,600
-81% -$45.4M 0.01% 1068
2025
Q2 		$58.2M Buy
541,500
+343,000
+173% +$34.7M 0.06% 350
2025
Q1 		$20M Buy
198,500
+28,700
+17% +$2.89M 0.02% 686
2024
Q4 		$15.2M Buy
169,800
+106,600
+169% +$9.38M 0.02% 908
2024
Q3 		$5.3M Sell
63,200
-33,200
-34% -$2.62M 0.01% 1377
2024
Q2 		$7.42M Buy
96,400
+23,500
+32% +$1.72M 0.01% 1113
2024
Q1 		$4.99M Buy
72,900
+30,600
+72% +$1.97M 0.01% 1441
2023
Q4 		$2.45M Buy
42,300
+26,900
+175% +$1.44M ﹤0.01% 1869
2023
Q3 		$813K Sell
15,400
-17,900
-54% -$939K ﹤0.01% 2469
2023
Q2 		$1.8M Buy
+33,300
New +$1.74M 0.01% 1720
2023
Q1 		– Sell
-11,400
Closed -$527K – 3251
2022
Q4 		$527K Hold
11,400
– – ﹤0.01% 2254
2022
Q3 		$442K Sell
11,400
-27,400
-71% -$1.1M ﹤0.01% 2262
2022
Q2 		$1.45M Sell
38,800
-5,400
-12% -$220K 0.01% 1383
2022
Q1 		$1.96M Sell
44,200
-33,500
-43% -$1.45M 0.01% 1171
2021
Q4 		$3.3M Buy
77,700
+400
+0.5% +$16.8K 0.01% 979
2021
Q3 		$3.35M Sell
77,300
-50,100
-39% -$2.22M 0.01% 956
2021
Q2 		$5.45M Sell
127,400
-20,000
-14% -$841K 0.02% 688
2021
Q1 		$5.7M Buy
147,400
+98,800
+203% +$3.74M 0.03% 574
2020
Q4 		$1.75M Buy
48,600
+38,100
+363% +$1.37M 0.01% 1002
2020
Q3 		$401K Buy
+10,500
New +$405K 0.01% 1599

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Squarepoint's BSX Position: Q1 2026 in Review

Squarepoint reduced its Boston Scientific (BSX) stake by 48% in Q1 2026, selling an estimated $116M and leaving 1,589,914 shares worth $99.8M. The position accounts for 0.12% of the portfolio, ranked #167.

Squarepoint first reported a position in BSX in Q2 2015 and has held it in 35 quarters since. The position peaked at $289M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Squarepoint held 1,589,914 shares of Boston Scientific worth $99.8M as of Q1 2026.
  • Squarepoint sold 1,445,374 Boston Scientific shares in Q1 2026, an estimated $116M.
  • Boston Scientific made up 0.12% of Squarepoint's portfolio in Q1 2026, its #167 holding.
  • Squarepoint first reported a position in Boston Scientific in Q2 2015 and has held it in 35 quarters since.
  • Squarepoint's Boston Scientific position peaked at $289M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.